Naproxen ophthalmic solution to manage inflammation after phacoemulsification

Journal of Cataract and Refractive Surgery

Volumn 28, Issue 2, 2002, Pages 321-327

  Papa, Vincento ^a   Milazzo, Giovanni ^a   Santocono, Marcello ^a   Servolle, Valerie ^b   Sourdille, Philippe ^c   Santiago, Pierre Yves ^c   Darondeau, Jacques ^d   Cassoux, Nathalie ^e   LeHoang, Phuc ^e  

^a SIFI SpA   (Italy)

^b AAI France   (France)

^c Clinique Sourdille   (France)

^d Centre Ophthalmologique Clinique du Landy   (France)

^e Hospitalier la Pitié Salpetriére   (France)

Author keywords

[No Author keywords available]

Indexed keywords

DICLOFENAC; EYE DROPS; NAPROXEN; VOLTAREN OFTA;

ADULT; ARTICLE; BIOMICROSCOPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; EYE INFLAMMATION; FEMALE; HUMAN; LENS IMPLANT; MAJOR CLINICAL STUDY; MALE; PHACOEMULSIFICATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SLIT LAMP;

ANTERIOR CHAMBER; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DICLOFENAC; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LENS IMPLANTATION, INTRAOCULAR; MALE; NAPROXEN; OPHTHALMIC SOLUTIONS; PAIN, POSTOPERATIVE; PHACOEMULSIFICATION; PROSPECTIVE STUDIES; SAFETY; UVEITIS, ANTERIOR;

EID: 0036166313     PISSN: 08863350     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0886-3350(01)01077-X     Document Type: Article

References (23)

1. Preoperative and postoperative medications used for cataract surgery
2. Prostaglandin and eye
3. Release of prostaglandins in ocular inflammation in the rabbit
4. Analgesic-antipyretic and antiinflarnmatory agents and drugs employed in the treatment of gout
5. Anti-inflammatory drugs
6. Cyclo-oxygenase inhibitors in ophthalmology
7. The emerging roles of topical non-steroidal anti-inflammatory agents in ophthalmology
8. The role of nonsteroidal antiinflammatory drugs in ocular inflammation
9. Naproxen: A reappraisal of its pharmacology and therapeutic use in rheumatic diseases and pain states
10. Anti-inflammatory and analgesic properties of d-2-(6′-methoxy-2′-naphthyl)-propionic acid (naproxen)
11. Lipid mediators of tumor necrosis factor-α-induced uveitis
12. The effect of the prostaglandin-inhibitor naproxen on the endothelial cell-loss after cataract extraction
13. Prostaglandin inhibition and central corneal thickness after cataract extraction
14. Surgically induced diffuse scleritis following cataract surgery
15. Role of naproxen as anti-oxidant in selenite cataract
16. Dissociation between prostaglandin levels and blood flow to the retina and choroid in the newborn pig after nonsteroidal antiinflammatory drugs
17. Comparison of ocular prostaglandin synthesis inhibitors
18. Effects of sodium naproxen eye drops on rabbit ocular inflammation induced by sodium arachidonate
19. Effect of sodium naproxen on inflammatory response induced by anterior chamber paracentesis in the rabbit
20. Safety and tolerability of naproxen ophthalmic solution in comparison to placebo
21. Management of postoperative inflammation: Dexamethasone versus flurbiprofen, a quantitative study using the new flare cell meter
22. A comparison of topical diclofenac with prednisolone for postcataract inflammation
23. Pretreatment with topical diclofenac sodium to decrease postoperative inflammation